RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 34-44
  • As Rx deaths dip, heroin overdoses surge

    As Rx deaths dip, heroin overdoses surge
    Prescription drug deaths declined in 2012 for the first time in more than a decade, but a surge in fatal heroin overdoses wiped out the modest improvement, according to U.S. government statistics released Wednesday. Fatal heroin overdoses rose 35% to 5,...
  • Allergan seeks to bar Bill Ackman from voting amid takeover bid

    Attorneys for Botox maker Allergan Inc. asked a federal judge in Santa Ana on Tuesday to prohibit activist investor Bill Ackman's hedge fund from voting in a shareholder election that could decide a hotly contested takeover effort. At issue is a $50-...
  • Valeant says it's willing to raise offer for Allergan to $200 a share

    As shareholders of Botox maker Allergan Inc. prepare for a vote on the company's future, a Canadian suitor said it's willing to increase its offer to buy the Irvine firm. J. Michael Pearson, chief executive of Valeant Pharmaceuticals International Inc.,...
  • How to judge Medicare plans

    How to judge Medicare plans
    While much of the nation is preoccupied with Obamacare and picking new health insurance at work, older Americans have deadlines of their own coming up — involving Medicare. We're just a few days away from the two-month period when the nation's...
  • Valeant says it's willing to boost offer for Botox maker Allergan

    Valeant says it's willing to boost offer for Botox maker Allergan
    A Canadian company said it is willing to significantly increase its offer for Botox maker Allergan Inc., the latest chapter in the attempted takeover of the Irvine company. Valeant Pharmaceuticals International Inc. said it would be willing to pay up to...
  • Raw deal for AbbVie, but does anyone care?

    Raw deal for AbbVie, but does anyone care?
    AbbVie got hosed on its aborted Shire deal. Let's get that up top. It's also very hard to feel sorry for it. Sure, the North Chicago-based pharmaceutical business failed to score Adderall and the Irish outfit behind it. You can make all the cracks you...
  • Abbott earnings tumble as costs offset better sales

    Abbott earnings tumble as costs offset better sales
    Abbott Laboratories on Wednesday said third-quarter earnings tumbled 44 percent on a tax charge that offset an uptick in sales. The north suburban-based maker of infant formula, medical devices and drugs, said it earned $538 million in the most recent...
  • AbbVie says tax rule changes scuttled deal for Shire

     AbbVie says tax rule changes scuttled deal for Shire
    AbbVie is blaming the Obama administration for pulling the plug on its $55 billion proposed acquisition of Irish drugmaker Shire, asserting that the largest corporate deal of the year no longer made economic sense under new federal tax regulations. Late...
  • Ebola scams spreading as fears mount

    Ebola scams spreading as fears mount
    I can't tell you whether to believe assurances from those in power that the deadly Ebola virus will be kept in check, but there's no doubt that panicking can expose you to harm. Scams related to the Ebola outbreak are spreading and you aren't immune....
  • AbbVie shares drop as tax rules cloud Shire deal

    AbbVie shares drop as tax rules cloud Shire deal
    Shares in North Chicago-based AbbVie and other drugmakers fell Tuesday after the Obama administration this week issued a string of new rules to crack down on U.S. companies that seek to cut their tax bills by moving their addresses abroad. AbbVie shares...
  • U.S. doctor was treated with experimental Ebola drug TKM-Ebola

    U.S. doctor was treated with experimental Ebola drug TKM-Ebola
    An American doctor who is recovering from Ebola at a Nebraska hospital got an experimental Canadian drug as part of his treatment, hospital officials disclosed this week. Dr. Rick Sacra started receiving TKM-Ebola, manufactured by Canadian drug firmĀ ...